<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/25/agilent-technologies-nysea-posts-quarterly-earnings-results-beats-estimates-by-0-03-eps.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-25T21:34:42+00:00"/>
    <meta property="og:title" content="Agilent Technologies (NYSE:A) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS"/>
    <meta property="og:description" content="Agilent Technologies (NYSE:A) released its earnings results on Monday. The medical research company reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.03, RTT News reports. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. The business had revenue of $1.37 billion during […]"/>
  </head>
  <body>
    <article>
      <h1>Agilent Technologies (NYSE:A) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS</h1>
      <address><time datetime="2019-11-25T21:34:42+00:00">25 Nov 2019, 21:34</time> by <a rel="author" href="https://www.thecerbatgem.com/author/teresa" target="_blank">Teresa Graham</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/agilent_logo.jpg"/>
      </figure>
      <p>Agilent Technologies (NYSE:A) released its earnings results on Monday. The medical research company reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.03, <a href="https://www.rttnews.com/Calendar/Earnings.aspx">RTT News</a> reports. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. The business had revenue of $1.37 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same period last year, the business earned $0.81 earnings per share. The firm’s revenue was up 5.6% on a year-over-year basis. Agilent Technologies updated its Q1 guidance to $0.80-0.81 EPS and its FY20 guidance to $3.38-3.43 EPS.</p>
      <p><a href="https://www.marketbeat.com/stocks/NYSE/A/earnings/">A stock</a> traded up $1.14 during midday trading on Monday, reaching $80.26. The company had a trading volume of 2,639,825 shares, compared to its average volume of 2,209,196. The company has a market capitalization of $24.23 billion, a price-to-earnings ratio of 28.77, a price-to-earnings-growth ratio of 1.94 and a beta of 1.42. The stock has a 50 day moving average price of $76.30 and a 200-day moving average price of $72.89. Agilent Technologies has a 1-year low of $62.00 and a 1-year high of $82.27. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.13 and a quick ratio of 1.72.</p>
      <p>The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date of this dividend is Monday, December 30th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.16. Agilent Technologies’s payout ratio is 23.66%.</p>
      <p>In other Agilent Technologies news, CEO Michael R. Mcmullen sold 24,635 shares of Agilent Technologies stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $77.50, for a total value of $1,909,212.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through <a href="https://www.sec.gov/Archives/edgar/data/1090872/000112760219028485/xslF345X03/form4.xml">this link</a>. Also, Director Heidi Fields sold 4,000 shares of Agilent Technologies stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $78.56, for a total value of $314,240.00. Following the completion of the transaction, the director now owns 53,287 shares in the company, valued at approximately $4,186,226.72. The disclosure for this sale can be found <a href="https://www.sec.gov/Archives/edgar/data/1014330/000112760219029024/xslF345X03/form4.xml">here</a>. In the last ninety days, insiders sold 32,635 shares of company stock valued at $2,507,293.</p>
      <p>A has been the subject of several research reports. Piper Jaffray Companies raised their price target on Agilent Technologies from $83.00 to $86.00 and gave the company an “overweight” rating in a report on Thursday, August 15th. UBS Group downgraded Agilent Technologies from a “buy” rating to a “neutral” rating and set a $82.00 price target for the company. in a report on Friday, October 18th. Robert W. Baird reaffirmed an “outperform” rating and set a $82.00 price target (up previously from $79.00) on shares of Agilent Technologies in a report on Thursday, August 15th. Needham &amp; Company LLC raised their price target on Agilent Technologies to $92.00 and gave the company a “buy” rating in a report on Monday, August 19th. Finally, <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks Investment Research</a> downgraded Agilent Technologies from a “buy” rating to a “hold” rating and set a $75.00 price target for the company. in a report on Monday, August 19th. Seven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $83.67.</p>
      <p>
        <b>About Agilent Technologies</b>
      </p>
      <p>Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.</p>
      <p>Featured Story: <a href="https://www.marketbeat.com/market-data/52-week-lows/">What are trading strategies for the 52-week high/low?</a></p>
      <figure>
        <img src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=A"/>
      </figure>
    </article>
  </body>
</html>